(EN) Certain tricyclic polyhydroxylic compounds, and their pharmaceutically-acceptable salts, are inhibitors of tyrosine kinase enzymes, and so are useful for the control of tyrosine kinase dependent diseases (e.g., cancer, atherosclerosis).(FR) Certains composés tricycliques polyhydroxyliques, et leurs sels pharmaceutiquement acceptables sont des inhibiteurs des enzymes de tyrosine-kinase, et sont donc utiles pour le traitement des maladies liées à la tyrosine-kinase (par exemple, cancer, athérosclérose).
Identification of Tricyclic Analogs Related to Ellagic Acid as Potent/Selective Tyrosine Protein Kinase Inhibitors
作者:Robert L. Dow、Thomas T. Chou、Bruce M. Bechle、Colin Goddard、Eric R. Larson
DOI:10.1021/jm00040a015
日期:1994.7
inhibitor of the tyrosine-specific proteinkinase pp60src. This report details efforts directed toward the identification of tricyclic structures related to ellagic acid, with enhanced specificity for inhibition of pp60src over other proteinkinases. Phenanthridinone and carbazole core structures were selected for investigation, since N-functionalization allows for the synthesis of numerous analogs which can